EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 275 filers reported holding EMERGENT BIOSOLUTIONS INC in Q3 2021. The put-call ratio across all filers is 1.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $649,551 | +2.8% | 62,698 | +108.4% | 0.02% | -18.2% |
| Q3 2022 | $632,000 | +29.8% | 30,089 | +91.9% | 0.02% | 0.0% |
| Q2 2022 | $487,000 | -75.2% | 15,677 | -67.2% | 0.02% | -76.1% |
| Q1 2022 | $1,964,000 | +180.2% | 47,836 | +241.7% | 0.09% | +64.3% |
| Q3 2021 | $701,000 | +91.5% | 14,000 | +255.1% | 0.06% | +64.7% |
| Q1 2021 | $366,000 | -79.4% | 3,942 | -77.1% | 0.03% | -70.2% |
| Q3 2020 | $1,779,000 | +246.8% | 17,221 | +94.3% | 0.11% | +208.1% |
| Q1 2020 | $513,000 | +3.8% | 8,861 | -16.7% | 0.04% | -31.5% |
| Q4 2017 | $494,000 | +145.8% | 10,635 | +74.0% | 0.05% | +68.8% |
| Q4 2016 | $201,000 | -49.2% | 6,111 | -43.9% | 0.03% | -30.4% |
| Q1 2016 | $396,000 | +39.9% | 10,900 | +26.7% | 0.05% | +43.8% |
| Q2 2015 | $283,000 | -69.4% | 8,600 | -73.3% | 0.03% | -66.3% |
| Q1 2015 | $926,000 | – | 32,200 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Laurus Investment Counsel Inc. | 120,504 | $10,797,000 | 4.20% |
| SNYDER CAPITAL MANAGEMENT L P | 723,477 | $64,824,000 | 2.12% |
| Hillcrest Asset Management LLC | 161,428 | $14,464,000 | 1.97% |
| RICE HALL JAMES & ASSOCIATES, LLC | 587,727 | $52,660,000 | 1.85% |
| PALISADE CAPITAL MANAGEMENT, LP | 579,009 | $51,879,000 | 1.33% |
| Pier Capital, LLC | 109,786 | $9,837,000 | 1.04% |
| Paradiem, LLC | 21,320 | $2,286,000 | 0.97% |
| EARNEST PARTNERS LLC | 1,390,735 | $124,610,000 | 0.86% |
| Ridgewood Investments LLC | 10,004 | $1,034,000 | 0.82% |
| Tygh Capital Management, Inc. | 56,334 | $5,048,000 | 0.78% |